Scission of the p53-MDM2 Loop by Ribosomal Proteins

Genes and Cancer

Volumn 3, Issue 3-4, 2012, Pages 298-310

  Zhou, Xiang ^a   Liao, Jun Ming ^a   Liao, Wen Juan ^a   Lu, Hua ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; MDM2; MDMX; MDS; nucleolar stress; p53; ribosomal proteins; ribosomopathy

Indexed keywords

DNA; NEDD8 PROTEIN; PROTEIN MDM2; PROTEIN P53; RIBOSOME PROTEIN;

BLACKFAN DIAMOND ANEMIA; CARCINOGENESIS; CELL STRESS; COLORECTAL CANCER; DNA DAMAGE; ESOPHAGUS CANCER; GENE MUTATION; HUMAN; INHIBITION KINETICS; LYMPHOMA; MYELODYSPLASTIC SYNDROME; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; RIBOSOME; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84875509885     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912455200     Document Type: Review

References (133)

1. Toledo F,Wahl GM.Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.Nat Rev. 2006;6:909-23.
2. Riley T,Sontag E,Chen P,Levine A.Transcriptional control of human p53-regulated genes.Nat Rev. 2008;9:402-12.
3. Shvarts A,Steegenga WT,Riteco N, et al.MDMX: a novel p53-binding protein with some functional properties of MDM2.EMBO J. 1996;15:5349-57.
4. Juven T,Barak Y,Zauberman A,George DL,Oren M.Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.Oncogene. 1993;8:3411-6.
5. Wu X,Bayle JH,Olson D,Levine AJ.The p53-mdm-2 autoregulatory feedback loop.Genes Dev. 1993;7 (7A): 1126-32.
6. Barak Y,Juven T,Haffner R,Oren M.mdm2 expression is induced by wild type p53 activity.EMBO J. 1993;12:461-8.
7. Oliner JD,Pietenpol JA,Thiagalingam S,Gyuris J,Kinzler KW,Vogelstein B.Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.Nature. 1993;362:857-60.
8. Haupt Y,Maya R,Kazaz A,Oren M.Mdm2 promotes the rapid degradation of p53.Nature. 1997;387:296-9.
9. Kubbutat MH,Jones SN,Vousden KH.Regulation of p53 stability by Mdm2.Nature. 1997;387:299-303.
10. Fuchs SY,Adler V,Buschmann T,Wu X,Ronai Z.Mdm2 association with p53 targets its ubiquitination.Oncogene. 1998;17:2543-7.
11. Maya R,Balass M,Kim ST, et al.ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.Genes Dev. 2001;15:1067-77.
12. Blattner C,Hay T,Meek DW,Lane DP.Hypophosphorylation of Mdm2 augments p53 stability.Mol Cell Biol. 2002;22:6170-82.
13. Cheng Q,Chen L,Li Z,Lane WS,Chen J.ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.EMBO J. 2009;28:3857-67.
14. Cheng Q,Cross B,Li B,Chen L,Li Z,Chen J.Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage.Mol Cell Biol. 2011;31:4951-63.
15. Inuzuka H,Tseng A,Gao D, et al.Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.Cancer Cell. 2010;18:147-59.
16. Kruse JP,Gu W.Modes of p53 regulation.Cell. 2009;137:609-22.
17. Weber JD,Taylor LJ,Roussel MF,Sherr CJ,Bar-Sagi D.Nucleolar Arf sequesters Mdm2 and activates p53.Nat Cell Biol. 1999;1:20-6.
18. Zhang Y,Xiong Y.Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.Mol Cell. 1999;3:579-91.
19. Tao W,Levine AJ.P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.Proc Natl Acad Sci U S A. 1999;96:6937-41.
20. Honda R,Yasuda H.Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.EMBO J. 1999;18:22-7.
21. Weber JD,Kuo ML,Bothner B, et al.Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.Mol Cell Biol. 2000;20:2517-28.
22. Zhang Y,Lu H.Signaling to p53: ribosomal proteins find their way.Cancer Cell. 2009;16:369-77.
23. Fatica A,Tollervey D.Making ribosomes.Curr Opin Cell Biol. 2002;14:313-8.
24. Iapalucci-Espinoza S,Franze-Fernandez MT.Effect of protein synthesis inhibitors and low concentrations of actinomycin D on ribosomal RNA synthesis.FEBS Lett. 1979;107:281-4.
25. Perry RP,Kelley DE.Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species.J Cell Physiol. 1970;76:127-39.
26. Wilkinson DS,Pitot HC.Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine.J Biol Chem. 1973;248:63-8.
27. Kanamaru R,Kakuta H,Sato T,Ishioka C,Wakui A.The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.Cancer Chemother Pharmacol. 1986;17:43-6.
28. Ghoshal K,Jacob ST.Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.Cancer Res. 1994;54:632-6.
29. Sun XX,Dai MS,Lu H.Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11.J Biol Chem. 2008;283:12387-92.
30. Pestov DG,Strezoska Z,Lau LF.Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.Mol Cell Biol. 2001;21:4246-55.
31. Dai MS,Sun XX,Lu H.Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.Mol Cell Biol. 2008;28:4365-76.
32. Yu W,Qiu Z,Gao N, et al.PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop.Nucleic Acids Res. 2011;39:2234-48.
33. Holzel M,Orban M,Hochstatter J, et al.Defects in 18 S or 28 S rRNA processing activate the p53 pathway.J Biol Chem. 2010;285:6364-70.
34. Sugimoto M,Kuo ML,Roussel MF,Sherr CJ.Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.Mol Cell. 2003;11:415-24.
35. Itahana K,Bhat KP,Jin A, et al.Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.Mol Cell. 2003;12:1151-64.
36. Bertwistle D,Sugimoto M,Sherr CJ.Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.Mol Cell Biol. 2004;24:985-96.
37. Ayrault O,Andrique L,Fauvin D,Eymin B,Gazzeri S,Seite P.Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.Oncogene. 2006;25:7577-86.
38. Lessard F,Morin F,Ivanchuk S, et al.The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I.Mol Cell. 2010;38:539-50.
39. Deisenroth C,Zhang Y.Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway.Oncogene. 2010;29:4253-60.
40. Fumagalli S,Di Cara A,Neb-Gulati A, et al.Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction.Nat Cell Biol. 2009;11:501-8.
41. Dutt S,Narla A,Lin K, et al.Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.Blood. 2011;117:2567-76.
42. Zhou X,Hao Q,Liao J,Zhang Q,Lu H.Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.Oncogene. 2012;:.
43. Sun XX,DeVine T,Challagundla KB,Dai MS.Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress.J Biol Chem. 2011;286:22730-41.
44. Burger K,Muhl B,Harasim T, et al.Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.J Biol Chem. 2010;285:12416-25.
45. Llanos S,Serrano M.Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.Cell Cycle. 2010;9:4005-12.
46. Narla A,Ebert BL.Ribosomopathies: human disorders of ribosome dysfunction.Blood. 2010;115:3196-205.
47. Barlow JL,Drynan LF,Hewett DR, et al.A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.Nat Med. 2010;16:59-66.
48. Ebert BL,Pretz J,Bosco J, et al.Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.Nature. 2008;451:335-9.
49. Golomb L,Bublik DR,Wilder S, et al.Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis.Mol Cell. 2012;45:222-32.
50. Marechal V,Elenbaas B,Piette J,Nicolas JC,Levine AJ.The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes.Mol Cell Biol. 1994;14:7414-20.
51. Rubbi CP,Milner J.Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.EMBO J. 2003;22:6068-77.
52. Lohrum MA,Ludwig RL,Kubbutat MH,Hanlon M,Vousden KH.Regulation of HDM2 activity by the ribosomal protein L11.Cancer Cell. 2003;3:577-87.
53. Zhang Y,Wolf GW,Bhat K, et al.Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.Mol Cell Biol. 2003;23:8902-12.
54. Dai MS,Zeng SX,Jin Y,Sun XX,David L,Lu H.Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.Mol Cell Biol. 2004;24:7654-68.
55. Dai MS,Lu H.Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.J Biol Chem. 2004;279:44475-82.
56. Jin A,Itahana K,O'Keefe K,Zhang Y.Inhibition of HDM2 and activation of p53 by ribosomal protein L23.Mol Cell Biol. 2004;24:7669-80.
57. Zhang Y,Xiong Y,Yarbrough WG.ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.Cell. 1998;92:725-34.
58. Kamijo T,Weber JD,Zambetti G,Zindy F,Roussel MF,Sherr CJ.Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.Proc Natl Acad Sci U S A. 1998;95:8292-7.
59. Stott FJ,Bates S,James MC, et al.The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.EMBO J. 1998;17:5001-14.
60. Kamijo T,Zindy F,Roussel MF, et al.Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.Cell. 1997;91:649-59.
61. Zhu Y,Poyurovsky MV,Li Y, et al.Ribosomal protein S7 is both a regulator and a substrate of MDM2.Mol Cell. 2009;35:316-26.
62. Chen D,Zhang Z,Li M, et al.Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.Oncogene. 2007;26:5029-37.
63. Yadavilli S,Mayo LD,Higgins M,Lain S,Hegde V,Deutsch WA.Ribosomal protein S3: a multi-functional protein that interacts with both p53 and MDM2 through its KH domain.DNA Repair. 2009;8:1215-24.
64. Xiong X,Zhao Y,He H,Sun Y.Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator.Oncogene. 2011;30:1798-811.
65. Zhang Y,Wang J,Yuan Y, et al.Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26.Nucleic Acids Res. 2010;38:6544-54.
66. Daftuar L,Zhu Y,Prives C.Ribosomal protein L37 and the p53 network.Cell Cycle. 2010;9:4259.
67. Sasaki M,Kawahara K,Nishio M, et al.Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.Nat Med. 2011;17:944-51.
68. Macias E,Jin A,Deisenroth C, et al.An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.Cancer Cell. 2010;18:231-43.
69. Lindstrom MS,Jin A,Deisenroth C,White Wolf G,Zhang Y.Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.Mol Cell Biol. 2007;27:1056-68.
70. Xirodimas DP,Sundqvist A,Nakamura A,Shen L,Botting C,Hay RT.Ribosomal proteins are targets for the NEDD8 pathway.EMBO Rep. 2008;9:280-6.
71. Sundqvist A,Liu G,Mirsaliotis A,Xirodimas DP.Regulation of nucleolar signalling to p53 through NEDDylation of L11.EMBO Rep. 2009;10:1132-9.
72. Mahata B,Sundqvist A,Xirodimas DP.Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner.Oncogene. 2011;:.
73. Ofir-Rosenfeld Y,Boggs K,Michael D,Kastan MB,Oren M.Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.Mol Cell. 2008;32:180-9.
74. Dai MS,Shi D,Jin Y, et al.Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.J Biol Chem. 2006;281:24304-13.
75. Tang Y,Zhao W,Chen Y,Zhao Y,Gu W.Acetylation is indispensable for p53 activation.Cell. 2008;133:612-26.
76. Flores ER,Tsai KY,Crowley D, et al.p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.Nature. 2002;416:560-4.
77. Bialik S,Berissi H,Kimchi A.A high throughput proteomics screen identifies novel substrates of death-associated protein kinase.Mol Cell Proteomics. 2008;7:1089-98.
78. Kim TS,Kim HD,Shin HS,Kim J.Phosphorylation status of nuclear ribosomal protein S3 is reciprocally regulated by protein kinase C{delta} and protein phosphatase 2A.J Biol Chem. 2009;284:21201-8.
79. Lee SB,Kwon IS,Park J, et al.Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA Repair.J Biol Chem. 2010;285:29457-68.
80. Ventimiglia FA,Wool IG.A kinase that transfers the gamma-phosphoryl group of GTP to proteins of eukaryotic 40S ribosomal subunits.Proc Natl Acad Sci U S A. 1974;71:350-4.
81. Ruvinsky I,Meyuhas O.Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.Trends Biochem Sci. 2006;31:342-8.
82. Choudhary C,Kumar C,Gnad F, et al.Lysine acetylation targets protein complexes and co-regulates major cellular functions.Science. 2009;325:834-40.
83. Wade M,Wang YV,Wahl GM.The p53 orchestra: Mdm2 and Mdmx set the tone.Trends Cell Biol. 2010;20:299-309.
84. Marine JC,Jochemsen AG.Mdmx and Mdm2: brothers in arms?.Cell Cycle. 2004;3:900-4.
85. Tanimura S,Ohtsuka S,Mitsui K,Shirouzu K,Yoshimura A,Ohtsubo M.MDM2 interacts with MDMX through their RING finger domains.FEBS Lett. 1999;447:5-9.
86. Badciong JC,Haas AL.MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination.J Biol Chem. 2002;277:49668-75.
87. Sharp DA,Kratowicz SA,Sank MJ,George DL.Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.J Biol Chem. 1999;274:38189-96.
88. Gilkes DM,Chen L,Chen J.MDMX regulation of p53 response to ribosomal stress.EMBO J. 2006;25:5614-25.
89. Jin Y,Dai MS,Lu SZ, et al.14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.EMBO J. 2006;25:1207-18.
90. Li M,Gu W.A critical role for noncoding 5S rRNA in regulating Mdmx stability.Mol Cell. 2011;43:1023-32.
91. Kim YJ,Cho YE,Kim YW,Kim JY,Lee S,Park JH.Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas.J Pathol. 2008;216:218-24.
92. Nakagawa Y,Yoshida A,Numoto K, et al.Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization.Oncol Rep. 2006;15:297-303.
93. Merritt MA,Parsons PG,Newton TR, et al.Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.BMC Cancer. 2009;9:378.
94. Okahara F,Ikawa H,Kanaho Y,Maehama T.Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.J Biol Chem. 2004;279:45300-3.
95. Okahara F,Itoh K,Nakagawara A,Murakami M,Kanaho Y,Maehama T.Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.Mol Biol Cell. 2006;17:4888-95.
96. Yim JH,Kim YJ,Ko JH, et al.The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death.Cell Death Differ. 2007;14:1872-9.
97. Cairncross JG,Ueki K,Zlatescu MC, et al.Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer Inst. 1998;90:1473-9.
98. Smith JS,Alderete B,Minn Y, et al.Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.Oncogene. 1999;18:4144-52.
99. Mariani L,Deiana G,Vassella E, et al.Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.J Clin Oncol. 2006;24:4758-63.
100. Lee S,Kim JY,Kim YJ, et al.Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.Cell Death Differ. 2012;:.
101. Dai MS,Challagundla KB,Sun XX, et al.Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.J Biol Chem. 2012;:.
102. Kawai H,Wiederschain D,Yuan ZM.Critical contribution of the MDM2 acidic domain to p53 ubiquitination.Mol Cell Biol. 2003;23:4939-47.
103. Zhang Q,Xiao H,Chai SC,Hoang QQ,Lu H.Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.J Biol Chem. 2011;286:38264-74.
104. Lessard F,Stefanovsky V,Tremblay MG,Moss T.The cellular abundance of the essential transcription termination factor TTF-I regulates ribosome biogenesis and is determined by MDM2 ubiquitinylation.Nucleic Acids Res. 2012;:.
105. Manfredi JJ.The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.Genes Dev. 2010;24:1580-9.
106. Brown DR,Thomas CA,Deb SP.The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis.EMBO J. 1998;17:2513-25.
107. Dang J,Kuo ML,Eischen CM,Stepanova L,Sherr CJ,Roussel MF.The RING domain of Mdm2 can inhibit cell proliferation.Cancer Res. 2002;62:1222-30.
108. Budde A,Grummt I.p53 represses ribosomal gene transcription.Oncogene. 1999;18:1119-24.
109. Zhai W,Comai L.Repression of RNA polymerase I transcription by the tumor suppressor p53.Mol Cell Biol. 2000;20:5930-8.
110. White RJ.RNA polymerases I and III, growth control and cancer.Nat Rev. 2005;6:69-78.
111. Krastev DB,Slabicki M,Paszkowski-Rogacz M, et al.A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly.Nat Cell Biol. 2011;13:809-18.
112. Barna M,Pusic A,Zollo O, et al.Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.Nature. 2008;456:971-5.
113. Grewal SS,Li L,Orian A,Eisenman RN,Edgar BA.Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development.Nat Cell Biol. 2005;7:295-302.
114. Grandori C,Gomez-Roman N,Felton-Edkins ZA, et al.c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I.Nat Cell Biol. 2005;7:311-8.
115. Arabi A,Wu S,Ridderstrale K, et al.c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription.Nat Cell Biol. 2005;7:303-10.
116. Dai MS,Arnold H,Sun XX,Sears R,Lu H.Inhibition of c-Myc activity by ribosomal protein L11.EMBO J. 2007;26:3332-45.
117. Challagundla KB,Sun XX,Zhang X, et al.Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.Mol Cell Biol. 2011;31:4007-21.
118. Flygare J,Karlsson S.Diamond-Blackfan anemia: erythropoiesis lost in translation.Blood. 2007;109:3152-4.
119. Gazda HT,Sheen MR,Vlachos A, et al.Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients.Am J Hum Genet. 2008;83:769-80.
120. Cmejla R,Cmejlova J,Handrkova H, et al.Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia.Hum Mutat. 2009;30:321-7.
121. Draptchinskaia N,Gustavsson P,Andersson B, et al.The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia.Nat Genet. 1999;21:169-75.
122. Jaako P,Flygare J,Olsson K, et al.Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia.Blood. 2011;118:6087-96.
123. Jones NC,Lynn ML,Gaudenz K, et al.Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.Nat Med. 2008;14:125-33.
124. Chakraborty A,Uechi T,Higa S,Torihara H,Kenmochi N.Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response.PloS One. 2009;4:e4152.
125. Danilova N,Sakamoto KM,Lin S.Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects.Br J Haematol. 2011;152:217-28.
126. Danilova N,Sakamoto KM,Lin S.Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family.Blood. 2008;112:5228-37.
127. Uechi T,Nakajima Y,Chakraborty A,Torihara H,Higa S,Kenmochi N.Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia.Hum Mol Genet. 2008;17:3204-11.
128. Duan J,Ba Q,Wang Z, et al.Knockdown of ribosomal protein S7 causes developmental abnormalities via p53 dependent and independent pathways in zebrafish.Int J Biochem Cell Biol. 2011;43:1218-27.
129. Taylor AM,Humphries JM,White RM,Murphey RD,Burns CE,Zon LI.Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation.Exp Hematol. 2012;40:228 e5-37.
130. Horn HF,Vousden KH.Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.Oncogene. 2008;27:5774-84.
131. Sun XX,Wang YG,Xirodimas DP,Dai MS.Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.J Biol Chem. 2010;285:25812-21.
132. Wade M,Wahl GM.Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?.Mol Cancer Res. 2009;7:1-11.
133. Vaseva AV,Yallowitz AR,Marchenko ND,Xu S,Moll UM.Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.Cell Death Dis. 2011;2:e156.